SEC Form 4 · accession 0001209191-17-039203
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lynch
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2017 | A | 1,400 | $0.00 | A | 2,800 | D | |
| Common Stock | Jun 8, 2017 | M | 2,500 | $2.0864 | A | 5,300 | D | |
| Common StockF3 | Jun 8, 2017 | S | 2,500 | $110.195 | D | 2,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $111.00 | Jun 8, 2017 | A | 5,600 | A | — | Jun 8, 2027 | Common Stock | 5,600 | 5,600 | D |
| Stock Option (right to buy)F5 | $2.0864 | Jun 8, 2017 | M | 2,500 | D | — | Jul 31, 2021 | Common Stock | 2,500 | 4,508 | D |
Explanation of responses
- F1These restricted stock units for common stock vest 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.
- F2This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
- F3The range of prices for the transaction reported on this line was $110.00 to $110.65. The average weighted price was $110.1950. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option vests 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.
- F5This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011